Novartis AG (NVSEF)

Bally's Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	225,606	195,695	207,167	194,448	197,007	215,047
Market Cap Growth	8.50%	-5.54%	6.54%	-1.30%	-8.39%	0.07%
Enterprise Value	251,199	212,877	220,692	204,644	224,014	243,613
Last Close Price	114.61	92.92	96.69	84.10	80.09	85.93
PE Ratio	16.52	16.39	13.95	27.96	8.20	26.64
PS Ratio	4.09	3.78	4.44	4.47	4.48	4.31
PB Ratio	5.36	4.43	4.43	3.27	2.91	3.80
P/TBV Ratio	-	-	-	69.00	21.01	-
P/FCF Ratio	11.67	12.04	15.46	14.60	14.07	17.38
P/OCF Ratio	10.85	11.11	14.33	13.66	13.07	15.75
EV/Sales Ratio	4.62	4.12	4.73	4.71	5.09	4.88
EV/EBITDA Ratio	10.71	10.30	12.60	14.68	14.33	16.32
EV/EBIT Ratio	13.30	13.04	17.46	22.21	20.43	24.00
EV/FCF Ratio	13.00	13.10	16.47	15.36	16.00	19.69
Debt / Equity Ratio	0.78	0.71	0.57	0.47	0.46	0.67
Debt / EBITDA Ratio	1.37	1.50	1.49	1.97	1.95	2.49
Debt / FCF Ratio	1.69	1.93	1.97	2.10	2.22	3.08
Asset Turnover	0.55	0.51	0.43	0.35	0.34	0.41
Inventory Turnover	2.17	2.20	1.84	1.67	1.65	2.31
Quick Ratio	0.50	0.79	0.88	1.00	1.25	0.65
Current Ratio	0.82	1.03	1.16	1.29	1.51	0.90
Return on Equity (ROE)	32.49%	26.27%	16.15%	9.51%	36.80%	14.38%
Return on Assets (ROA)	11.88%	10.09%	7.27%	4.62%	5.28%	5.16%
Return on Capital (ROIC)	16.47%	13.72%	9.84%	6.18%	7.08%	7.07%
Return on Capital Employed (ROCE)	26.40%	22.20%	17.20%	10.40%	10.80%	10.70%
Earnings Yield	6.05%	6.10%	7.17%	3.58%	12.19%	3.75%
FCF Yield	8.57%	8.30%	6.47%	6.85%	7.11%	5.75%
Dividend Yield	3.48%	4.16%	4.05%	4.12%	4.25%	3.95%
Payout Ratio	57.26%	63.85%	48.85%	107.92%	30.67%	86.56%
Buyback Yield / Dilution	3.37%	2.73%	4.78%	2.79%	1.57%	0.99%
Total Shareholder Return	6.85%	6.88%	8.83%	6.90%	5.81%	4.94%

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.